SpaceX Stock Climbs Back Above Its $135 IPO Price -- Here's Where It Could Trade by August 2027

SpaceX shares surged above its $135 IPO price, closing Aug. 12 at $146.15, after earlier trading dipped to $104.83. The company’s Q2 results showed revenue up 92% to $7.8B and a reduced net loss to $542M (from $1B a year earlier), with management bringing forward its $1T revenue outlook to 2030. Analysts are largely bullish (75% “buy”), with a median 12-month target of $217—implying about a 48.4% upside from $146.15—though volatility risk remains given rapid post-IPO moves.

Analysis

The near-term tell is not the revenue print; it’s that the post-lockup sellable supply was absorbed without breaking the deal range. That usually marks the transition from “story stock” to “institutional sponsorship,” but it also means the easy re-rating can be mostly behind the shares. At this valuation, SPCX is trading on duration more than current earnings, so any slowdown in launch cadence, customer prepayments, or margin bridge will hit the multiple before it hits the P&L.

Second-order winners are the broader space ecosystem and private-market IPO candidates: a stable tape for SPCX lowers the discount rate on future listings and makes capital raises easier for adjacent names. The losers are lower-growth launch and satellite peers that get benchmarked against a higher-growth, higher-liquidity comp; if SPCX can keep compounding, it raises the bar for Rocket Lab-style narratives and compresses the premium on “next-gen space” stories that lack the same scale. For sector proxies, UFO/XAR would likely outperform only if this becomes a sustained risk-on tape rather than a single squeeze.

The key risk is that the move is being validated by analyst targets rather than by free-cash-flow visibility. If the next two quarters show revenue growth decelerating faster than loss narrowing, the stock can retrace to the IPO zone quickly; a break back below $135 on heavy volume would signal the supply overhang is not fully cleared. Over 6-18 months, the thesis holds only if SpaceX converts growth into operating leverage; otherwise, this remains a long-duration multiple story vulnerable to higher real rates and any insider distribution.

Key Decisions for Investors

• Do not chase SPCX here; wait for a retracement toward $135-140 before adding risk, with a tight thesis stop on a daily close below $128 and upside toward the $170s if the next print confirms margin improvement.
• For volatility capture, consider a 3-6 month SPCX call spread rather than outright stock if you want upside participation with defined downside; thesis fails if the stock re-enters the pre-IPO range and implied vol compresses.
• Relative-value idea: long SPCX / short UFO or XAR on any further strength if you believe the market will reward the highest-quality space platform while compressing weaker peers; exit if aerospace multiples expand broadly on a risk-on macro tape.
• Set an alert on the next quarterly release for gross margin and operating cash flow, not revenue growth; if loss narrowing stalls, treat the rally as sentiment-driven and fade it.
• If insider sales re-accelerate after the lockup window, use that as the signal to reduce exposure aggressively; that would be the clearest falsifier of the supply-absorption thesis.